X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (12946) 12946
Newsletter (2321) 2321
Publication (1821) 1821
Book Review (402) 402
Newspaper Article (239) 239
Book Chapter (104) 104
Book / eBook (44) 44
Conference Proceeding (23) 23
Magazine Article (21) 21
Transcript (21) 21
Dissertation (8) 8
Trade Publication Article (7) 7
Data Set (5) 5
Web Resource (4) 4
Government Document (3) 3
Reference (3) 3
Streaming Video (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9150) 9150
antiviral agents (7795) 7795
index medicus (6574) 6574
pharmacology & pharmacy (4028) 4028
male (3753) 3753
female (3564) 3564
antiviral agents - therapeutic use (3507) 3507
animals (3372) 3372
hiv (2981) 2981
adult (2549) 2549
antiviral agents - pharmacology (2483) 2483
antiviral agents - pharmacokinetics (2434) 2434
health aspects (2371) 2371
pharmacokinetics (2124) 2124
middle aged (2051) 2051
drug therapy (2029) 2029
research (2003) 2003
antiviral agents - administration & dosage (1906) 1906
infectious diseases (1763) 1763
virology (1718) 1718
hiv infections - drug therapy (1705) 1705
analysis (1658) 1658
infection (1647) 1647
hepatitis c (1555) 1555
microbiology (1527) 1527
hepatitis c virus (1482) 1482
treatment outcome (1460) 1460
virus diseases (1384) 1384
aids (1355) 1355
drug therapy, combination (1355) 1355
hepatitis c, chronic - drug therapy (1297) 1297
antiviral agents - adverse effects (1282) 1282
therapy (1253) 1253
viruses (1230) 1230
drugs (1206) 1206
hiv infection (1169) 1169
care and treatment (1151) 1151
antiviral activity (1146) 1146
highly active antiretroviral therapy (1114) 1114
gastroenterology & hepatology (1099) 1099
ribavirin (1097) 1097
anti-hiv agents (1037) 1037
medical research (1033) 1033
human immunodeficiency virus--hiv (1015) 1015
in-vitro (1007) 1007
chemistry, medicinal (1000) 1000
antiviral agents - chemistry (992) 992
infections (977) 977
mice (976) 976
drug interactions (954) 954
interferon (924) 924
rats (903) 903
hepatitis (886) 886
hepacivirus - drug effects (884) 884
immunology (882) 882
dosage and administration (877) 877
aged (874) 874
clinical trials (874) 874
protease inhibitors (871) 871
medicine, experimental (869) 869
human-immunodeficiency-virus (857) 857
virus replication - drug effects (814) 814
hiv-1 - drug effects (810) 810
dose-response relationship, drug (768) 768
administration, oral (766) 766
antiretroviral therapy (761) 761
viral load (759) 759
research article (749) 749
adolescent (740) 740
interferon-alpha - therapeutic use (728) 728
ribavirin - therapeutic use (718) 718
replication (716) 716
hepacivirus - genetics (715) 715
pharmacology (710) 710
hepatitis c - drug therapy (708) 708
biochemistry & molecular biology (700) 700
genotype (700) 700
article (689) 689
safety (679) 679
efficacy (666) 666
medicine & public health (651) 651
anti-hiv agents - therapeutic use (650) 650
cell line (650) 650
antiretroviral drugs (635) 635
medicine (631) 631
hiv patients (617) 617
liver (616) 616
drug resistance (612) 612
structure-activity relationship (612) 612
young adult (603) 603
risk factors (602) 602
virus-infection (595) 595
prevention (594) 594
pharmaceutical industry (573) 573
proteases (570) 570
antiviral (563) 563
resistance (562) 562
transplantation (562) 562
recombinant proteins (555) 555
antiviral therapy (550) 550
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (29) 29
Online Resources - Online (5) 5
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Credit Valley Hospital - Stacks (1) 1
Dentistry (Harry R Abbott) - Stacks (1) 1
Earth Sciences (Noranda) - Stacks (1) 1
Scarborough Hospital - Hospital Department (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Toronto East General Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (15496) 15496
French (37) 37
Spanish (31) 31
Russian (26) 26
Chinese (21) 21
German (20) 20
Japanese (20) 20
Korean (13) 13
Hungarian (6) 6
Polish (5) 5
Italian (4) 4
Dutch (3) 3
Portuguese (3) 3
Danish (2) 2
Swedish (2) 2
Arabic (1) 1
Bulgarian (1) 1
Czech (1) 1
Finnish (1) 1
Turkish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 01/2016, Volume 60, Issue 1, pp. 105 - 114
Journal Article
Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 07/2013, Volume 159, Issue 2, pp. 86 - 96
Background: Telaprevir (TVR) plus peginterferon-alpha 2a (PEG-IFN-alpha 2a) and ribavirin substantially increases treatment efficacy for genotype 1 chronic... 
Vertex pharmaceuticals and janssen pharmaceuticals | MEDICINE, GENERAL & INTERNAL | MANAGEMENT | PREDICTORS | ALPHA-2A PLUS RIBAVIRIN | BOCEPREVIR | HCV | ANEMIA | VIROLOGICAL RESPONSE | ASSOCIATION | HIV-1 | Recombinant Proteins - therapeutic use | Antiviral Agents - pharmacokinetics | Humans | Middle Aged | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Polyethylene Glycols - adverse effects | Male | Recombinant Proteins - pharmacokinetics | Recombinant Proteins - adverse effects | Oligopeptides - adverse effects | Polyethylene Glycols - therapeutic use | Oligopeptides - therapeutic use | Ribavirin - pharmacokinetics | Interferon-alpha - pharmacokinetics | Adult | Anti-HIV Agents - therapeutic use | Female | Drug Therapy, Combination | Double-Blind Method | Antiviral Agents - therapeutic use | Oligopeptides - pharmacokinetics | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Polyethylene Glycols - pharmacokinetics | Genotype | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Ribavirin - adverse effects | Antiviral Agents - adverse effects | HIV Infections - complications | Interferon-alpha - adverse effects | Antiviral agents | Patient outcomes | Dosage and administration | Drug therapy, Combination | Research | Hepatitis C | Drug therapy | HIV infection | Index Medicus | Abridged Index Medicus
Journal Article
Epilepsia, ISSN 0013-9580, 01/2013, Volume 54, Issue 1, pp. 11 - 27
Summary Several commonly prescribed antiepileptic drugs (AEDs)—including phenobarbital, phenytoin, and carbamazepine—stimulate the synthesis of a broad range... 
Enzyme‐inducing antiepileptic drug | Vascular disease | Drug metabolism | Pharmacokinetic interactions | Osteoporosis | Sexual dysfunction | Enzyme-inducing antiepileptic drug | DOSE-DEPENDENT INDUCTION | VASCULAR RISK-FACTORS | VITAMIN-D METABOLISM | NEWLY-DIAGNOSED EPILEPSY | QUALITY STANDARDS SUBCOMMITTEE | PREGNANE-X-RECEPTOR | CLINICAL NEUROLOGY | PATIENTS RECEIVING CARBAMAZEPINE | RECURRENT MALIGNANT GLIOMA | BRAIN-TUMOR CONSORTIUM | INCREASED BONE TURNOVER | Anticonvulsants - pharmacokinetics | Anti-Retroviral Agents - pharmacokinetics | Humans | Immunosuppressive Agents - pharmacokinetics | Anticonvulsants - therapeutic use | Male | Vascular Diseases - chemically induced | Pregnancy | Cytochromes - biosynthesis | Anticonvulsants - adverse effects | Drug Interactions | Enzyme Induction - drug effects | Epilepsy - drug therapy | Female | Antineoplastic Agents - pharmacokinetics | Contraceptives, Oral, Hormonal - pharmacokinetics | Antidepressive Agents - pharmacokinetics | Drugs | Antiviral agents | Enzymes | Corticosteroids | Comorbidity | Epilepsy | Anticoagulants (Medicine) | Blood circulation disorders | Phenobarbital | Physiological aspects | Hormones, Sex | Oral contraceptives | Sexual disorders | Statins | Phenytoin | Anticoagulants | Glucocorticoids | Antihypertensives | Toxicity | Withdrawal | Mortality | Antiepileptic agents | Immunosuppressive agents | Graft rejection | Sex hormones | Vascular diseases | Acquired immune deficiency syndrome | Analgesics | statins | Metabolic pathways | Cancer | Index Medicus
Journal Article
Biopharmaceutics & Drug Disposition, ISSN 0142-2782, 11/2011, Volume 32, Issue 8, pp. 427 - 445
Journal Article
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 03/2014, Volume 57, Issue 5, pp. 2047 - 2057
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2015, Volume 63, Issue 4, pp. 805 - 812
Background & Aims Paritaprevir, ombitasvir, and dasabuvir are direct-acting antivirals for treatment of chronic hepatitis C virus (HCV) infection. The aim of... 
Gastroenterology and Hepatology | Direct-acting antiviral agents | Ombitasvir | Chronic hepatitis C | Hepatic impairment | Ritonavir | Paritaprevir | Pharmacokinetics | Dasabuvir | ABT-450/R-OMBITASVIR | TRANSPORTER EXPRESSION | RIBAVIRIN | LIVER-DISEASE | GENOTYPE 1 | THERAPY | CIRRHOSIS | HCV | GASTROENTEROLOGY & HEPATOLOGY | Antiviral Agents - pharmacokinetics | Humans | Middle Aged | Cytochrome P-450 CYP3A Inhibitors - pharmacokinetics | Male | Anilides - pharmacokinetics | Carbamates - administration & dosage | Hepatitis C, Chronic - complications | Carbamates - pharmacokinetics | Dose-Response Relationship, Drug | Uracil - administration & dosage | Ribavirin - administration & dosage | Ribavirin - pharmacokinetics | Female | Drug Therapy, Combination | Liver Function Tests | Cytochrome P-450 CYP3A Inhibitors - administration & dosage | Ritonavir - administration & dosage | Macrocyclic Compounds - pharmacokinetics | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Hepatic Insufficiency - blood | Hepatitis C, Chronic - blood | Sulfonamides - pharmacokinetics | Ritonavir - pharmacokinetics | Anilides - administration & dosage | Macrocyclic Compounds - administration & dosage | Hepatic Insufficiency - etiology | Uracil - pharmacokinetics | Sulfonamides - administration & dosage | Uracil - analogs & derivatives | Antiviral agents | Safety and security measures | Hepatitis C virus | Hepatitis C
Journal Article
Journal Article